Reliability of eye tracking and pupillometry measures in individuals with fragile X syndrome.
Recent insight into the underlying molecular and cellular mechanisms of fragile X syndrome (FXS) has led to the proposal and development of new pharmaceutical treatment strategies, and the initiation of clinical trials aimed at correcting core symptoms of the developmental disorder. Consequently, there is an urgent and critical need for outcome measures that are valid for quantifying specific symptoms of FXS and that are consistent across time. We used eye tracking to evaluate test-retest reliability of gaze and pupillometry measures in individuals with FXS and we demonstrate that these measures are viable options for assessing treatment-specific outcomes related to a core behavioral feature of the disorder.
Department of Psychology, Stanford University, 450 Serra Mall, Stanford, CA 94305, USA. ffarzin@stanford.edu
Faraz
F
Farzin
Felicia
F
Scaggs
Crystal
C
Hervey
Elizabeth
E
Berry-Kravis
David
D
Hessl
D000293:Adolescent; D000328:Adult; D002648:Child; D005133:Eye Movements / Q000187:drug effects; D005260:Female; D005600:Fragile X Syndrome / Q000188:drug therapy / Q000523:psychology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests; D011680:Pupil / Q000187:drug effects; D015203:Reproducibility of Results; D016896:Treatment Outcome; D055815:Young Adult
Psychophysiology. 2008 Jul;45(4):602-7
18282202
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50
12032354
J Neurosci. 2002 Jun 15;22(12):5219-29
12077217
J Autism Dev Disord. 2005 Feb;35(1):103-16
15796126
Psychoneuroendocrinology. 2002 Oct;27(7):855-72
12183220
Biol Psychiatry. 2007 Feb 15;61(4):512-20
17069771
Genet Med. 2001 Sep-Oct;3(5):359-71
11545690
J Med Genet. 2009 Apr;46(4):266-71
19126569
J Autism Dev Disord. 2009 Jun;39(6):946-52
19399604
Arch Gen Psychiatry. 2004 Mar;61(3):281-8
14993116
Neuropharmacology. 2005 Dec;49(7):1053-66
16054174
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7101-6
11416194
Am J Ment Defic. 1985 Mar;89(5):485-91
3993694
Curr Opin Neurobiol. 2009 Jun;19(3):319-26
19411173
Trends Neurosci. 2004 Jul;27(7):370-7
15219735
J Child Psychol Psychiatry. 2006 Jun;47(6):602-10
16712637
J Child Psychol Psychiatry. 1989 Nov;30(6):845-56
2592468
Neuroimage. 2008 Nov 15;43(3):592-604
18778781
Nat Genet. 1993 Aug;4(4):335-40
8401578
J Autism Dev Disord. 1988 Sep;18(3):343-54
3170453
J Neurosci. 2005 Aug 10;25(32):7385-92
16093389
Genes Brain Behav. 2005 Aug;4(6):393-8
16098137
Am J Ment Retard. 1988 Mar;92(5):436-46
2965890
Dev Disabil Res Rev. 2009;15(4):333-42
20014363
J Appl Behav Anal. 2009 Spring;42(1):171-6
19721738
J Autism Dev Disord. 2006 Oct;36(7):935-47
16897394
Neuron. 2005 Mar 3;45(5):753-64
15748850
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11591-6
20534533
Nat Rev Neurosci. 2005 May;6(5):376-87
15861180
Am J Med Genet. 2002 Aug 1;111(2):140-6
12210340
Cell. 1991 May 31;65(5):905-14
1710175
J Am Acad Child Adolesc Psychiatry. 2009 Mar;48(3):320-329
19182690